At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Engager™ aortic valvedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Engager Direct Aortic Clinical Study: Medtronic Engager™ Transcatheter Aortic Valve Implantation System Via Direct Aortic Approach
In Brief
A clinical study evaluating Engager™ aortic valve for Aortic Valve Stenosis. Completed, enrolled 20 participants across 6 sites in 3 countries.
Detailed Summary
To confirm the safety and performance of the Medtronic Engager™ Transcatheter Aortic Valve Implantation System via direct aortic approach.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Valve Stenosis
CountriesCzechia, Germany, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 2013
Enrollment StartMay 2013
Primary CompletionJul 2014
Study CompletionJun 2015
TodayJul 2026
First PostedFeb 12, 2013
Enrollment StartMay 1, 2013
Primary CompletionJul 1, 2014
Study CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 13.4 years ago
Interventions
Engager™ aortic valvedevice
Implantation of the Medtronic Engager™ bioprosthesis via direct aortic approach